Skip to main content

Assessing consumers’ perception and demand on the community pharmacists’ dispensing

Abstract

Background

This study aimed to assess the general public's perception of services provided by community pharmacies, their willingness to utilize these services, their satisfaction with and understanding of community pharmacists, and their views on dispensing separation and pharmacy medicines (P medicines).

Methods

An online cross-sectional study was conducted, in which questionnaires were distributed among the general public. A novel questionnaire was designed and validated specifically for this study. It was composed of six sections: demographics, pharmacy usage and service preferences, understanding and satisfaction with pharmacists, views on dispensing separation, private community pharmacies, and knowledge of P medicines. Statistical analyses such as one-way ANOVA, independent t test, and binary logistic regression were employed, with a p value of < 0.05 considered statistically significant.

Results

The study received 222 responses. The majority of the respondents were females within the 20–29-year-old age group (62.2%). Most respondents preferred to consult doctors for medical treatment, with their primary reason for visiting community pharmacies being to collect prescribed medicines. About 52.7% of respondents expressed their willingness to avail of screening services and treatment for minor illnesses at community pharmacies. A statistically significant difference was found among different age groups regarding their views on the dispensing separation system, with those aged 41–50 years demonstrating higher scores. However, the binary logistic regression analysis did not reveal any statistical significance when comparing the understanding of P medicines among respondents.

Conclusions

In general, the public prefers to consult doctors for medical treatment and visit community pharmacies predominantly to collect prescriptions or purchase over-the-counter medications. Nonetheless, they are also open to utilizing services provided by community pharmacists, particularly screening services and treatment for minor illnesses.

Background

Pharmacy is one of the largest healthcare professional groups worldwide [1]. In the past, the pharmacist’s role involved obtaining chemical ingredients, manufacturing, and supplying medicinal products—a role now performed by the pharmaceutical industry. Today, the primary roles of community pharmacists are dispensing and retailing [2]. Despite their extensive professional training, the capabilities of community pharmacists are underutilized. Their roles should ideally be expanded to more clinically oriented, patient-centered services. Such an expansion could enhance health outcomes by promoting better medication adherence, reducing drug-related adverse events, and decreasing unnecessary provider visits, hospitalizations, and readmissions [1]. Furthermore, growing knowledge and technological advancements have heightened expectations for pharmacists to provide more efficient primary care services [3].

There are two main types of pharmacies: hospital and community pharmacies. Hospital pharmacies are located within hospitals, while community pharmacies, typically situated within the community, are more accessible [4]. In some countries, the public prefers visiting community pharmacies due to their convenience—no appointments are required, and they offer extended opening hours [5]. These pharmacies are often chosen as the first point of contact for minor illnesses, such as coughs and colds [5]. Unlike most countries where community pharmacies are privately owned, in Brunei, both health center and private pharmacies are categorized as community pharmacies.

According to the Ministry of Health (MOH), the community pharmacy services in Brunei are confined to dispensing medications as prescribed by doctors, adhering to Good Dispensing Practice (GDP), providing patient counseling about their medications, and supplying floor stock medications to peripheral clinics [6]. These services constitute core pharmacy services rather than the enhanced or expanded community pharmacy services for patient-centered care [7].

Systematic reviews and meta-analyses have demonstrated that the expansion of clinical services by community pharmacies has been successfully adopted and implemented [8, 9]. Recently, New Zealand implemented a substantial reform of its community pharmacy sector through the new Community Pharmacy Services Agreement (CPSA). The country transitioned from a reimbursement-per-dispensing model to a patient-centered services model [2]. To execute the clinical activities, consultation rooms and additional staff with appropriate expertise may be required. Consumer demand is also crucial for successful implementation [10].

Many countries already offer enhanced services. For instance, the UK introduced expanded services in 2005 [11]. The services are divided into three categories: essential, advanced, and locally commissioned. Essential services, such as dispensing and signposting to patients, are traditional services originally provided by community pharmacies. Advanced services require more patient interaction and communication, with pharmacies offering one-to-one consultations and medication reviews. As a result, consultation rooms have become more common in community pharmacies to ensure privacy. Finally, locally commissioned services are broader and cover a wide range of medication and public health services, such as managing minor illnesses (e.g., cough and cold), offering lifestyle advice, and providing sexual health services [12]. A published study revealed that most participants are willing to accept the majority of these extended services [13]. However, patients may only be familiar with the traditional roles of community pharmacists, namely, checking prescriptions, dispensing, and counseling on medication, as indicated by studies assessing the public's views on community pharmacies and pharmacists [14, 15].

Pharmacists’ dispensing roles can be constrained by the classification of medicines, which are categorized into three types: Prescription Only Medicines (POM), Pharmacy Medicine (P medicines), and General Sales List (GSL). POM can only be prescribed by doctors and dispensed with a valid and complete prescription. P medicines, on the other hand, can be purchased from a pharmacy without a prescription but require the presence of a pharmacist. These medicines are usually stored behind the counter in pharmacies and not in open areas. GSL medicines can be sold anywhere—retail stores, supermarkets, or other shops [16]. In Brunei, the Brunei Darussalam Medicines Control Authority (BDMCA) regulates medication classification.

The Poisons List, overseen by the Poisons Act, regulates the importation and sales of poisons, including prohibitions and provisions related to poison sales [17]. The current Poison List allows only a limited number of items to be dispensed by pharmacists without a prescription. This limitation, along with an imbalance in classified medications and a lack of dispensing separation, has restricted the roles of pharmacists in managing minor illnesses, such as mild pain and cough [17].

Information on the expanded or enhanced community pharmacy services in Brunei Darussalam remains scarce, hindering the assessment process needed for successful implementation of these services. Thus, this study aims to provide a clearer understanding of the general public’s perception of services offered by community pharmacies and their willingness to utilize them. It also seeks to evaluate public satisfaction with and understanding of community pharmacists. Finally, the study will examine attitudes and behaviors concerning access to P medicines and dispensing separation. The data gathered from this study should reflect Brunei’s current situation more accurately and may serve as a valuable reference for future policy development and implementation.

Methods

Study design, site, and participants

This online cross-sectional survey was conducted from March 2023 to April 2023 among the general public of Brunei Darussalam. Questionnaires were distributed at the RIPAS hospital and community pharmacies in accordance with the Ministry of Health in Brunei. Distribution also occurred via social media platforms (WhatsApp and Instagram), and emails. Posters containing relevant information and a QR code linking to the questionnaire (English version) were displayed at RIPAS hospital and community health centers. Emails were sent to university students via their respective registrars or departments. The targeted universities and colleges included Universiti Brunei Darussalam (UBD), Universiti Teknologi Brunei (UTB), Universiti Islam Sultan Sharif Ali (UNISSA), Institute of Brunei Technical Education (IBTE), Laksamana College of Business (LCB), and Politeknik Brunei (PB). The poster and QR codes were also included in emails, WhatsApp messages, and Instagram stories.

The inclusion criteria for this study were: (i) individuals aged 18 years and above and (ii) individuals residing in Brunei Darussalam. The exclusion criteria included: (i) adults temporarily residing in Brunei Darussalam and (ii) adults unwilling to participate.

Sample size

This study used a convenience sampling strategy. In this non-probability sampling approach, study inclusion primarily depended on potential participants’ convenience and willingness. This method does not require a predetermined sample size nor aims to be fully representative of the population. The objective was to expedite data collection and glean insights from an easily accessible group of individuals exhibiting characteristics relevant to the research question.

Study instrument

A questionnaire was designed after conducting a literature review of relevant studies [4, 13, 15, 18], to align with the local context in English (see Appendix 1). The Delphi technique was employed to reach a consensus on group opinion. To facilitate the Delphi method, the panel consisted of the principal investigator of this study along with experts specialized in the area of pharmacy and practice. The questionnaire comprises 44 questions divided into six sections. The sections gather information on respondents’ demographics, pharmacy usage, service preferences, understanding and satisfaction with pharmacists, views on the dispensing separation system, perception of private community pharmacies, and knowledge of P medicines. The questions were a mix of multiple-choice, checkbox ticking, Likert scale, and short-answer questions. Likert scale question scores ranged from 1 (very satisfied/very good) to 5 (very unsatisfied/very bad).

Pilot study

Initially, face and content validation was conducted among a small targeted sample of randomly selected respondents meeting the inclusion criteria. All participants reported that the questionnaire items were simple, clear, and aligned with the study objectives. Content validity was evaluated to determine the degree to which the instrument sufficiently covered the construct of interest. Each item was reviewed by the aforementioned experts who rated the item's content validity in terms of its relevance. The internal consistency of the questionnaire was assessed using an alpha value of 0.785, indicative of adequate questionnaire reliability. Furthermore, sampling adequacy was assessed through Bartlett’s test of sphericity and the Kaiser–Mayer–Olkin (KMO) measure. The KMO value was 0.802, and Bartlett’s test of sphericity was significant (df = 435, p < 0.001), suggesting adequate sampling adequacy.

Data collection and analysis

Questionnaires were distributed online via WhatsApp, emails, and Instagram over a 1-month period (March to April 2023). Participation was voluntary, and respondents could withdraw at any time by not completing the questionnaire or closing the questionnaire page. No participant-identifying information was collected.

Results

Respondents demographics

The respondents’ demographics are shown in Table 1. A total of 222 respondents completed the survey. The majority of them were female (n = 153, 68.9%) and of Brunei nationality (n = 190, 85.6%). The majority of the respondents were from the age group 20–29 years (n = 138, 62.2%). A higher proportion of respondents had an undergraduate degree (n = 90, 40.5%), and 85.1% (n = 189) completed their studies in Brunei. Most respondents are currently staying in the Brunei-Muara district (n = 177, 79.7%).

Table 1 Respondents demographics (n = 222)

Pharmacy usage and preference for services

Table 2 presents the respondents' preferred location for medical treatment, willingness to use services and preferences, and frequency of visits to community pharmacies. Nearly equal proportions of respondents preferred to receive medical treatment in public/government institutions (48.6%, n = 108) and private clinics (43.7%, n = 97), while 7.7% preferred private pharmacies. When asked about the reason, the majority responded, ‘I am used to it’ (34.2%, n = 76). Cost was another factor mentioned by respondents (4.1%), with public and government facilities being cheaper or free of charge. Private clinics were favored for their shorter waiting times and better quality of medicines (1.4%), while private pharmacies were chosen for their convenience. Additional reasons provided (n = 9) include effective and accurate treatment, professionalism and experience of pharmacists, ease of obtaining medications, greater trust in government and available facilities.

Table 2 Preference for medical treatment, services, and visits to community pharmacies

Regarding frequency of visits to community pharmacies, the majority of respondents (91.4%, n = 203) reported visiting once every few months, 7.2% (n = 16) once a month, and 1.4% (n = 3) once a week. Approximately 40.5% (n = 90) of respondents last visited a community pharmacy a few months ago. Close to half of the respondents (46.8%, n = 104) reported visiting community pharmacies to collect prescription medicines, while 41.4% (n = 92) visited to purchase over-the-counter (OTC) medications. Fewer respondents visit the pharmacy for medication advice (n = 9) and counselling for medication use (n = 8). Other reasons for visiting community pharmacies (n = 9) included having flu, fever, or cough, injuries, and seeking toiletries, with some reporting rarely visiting the community pharmacy.

Respondents were asked about their willingness to use services provided by community pharmacies, with answer options being ‘Yes’, ‘No’, and ‘Maybe’. Over half (52.7%) selected 'yes', 5% ‘no’, and 42.3% ‘maybe’. Respondents showed a high level of acceptance of services provided by community pharmacies, with all options being chosen at least once. Among respondents who selected ‘Yes’, ‘screening services’ (72.6%, 85/117), ‘treating minor illnesses’ (67.5%, 79/117), and ‘skin care management’ (64.1%, 75/117) were the most preferred services, while ‘smoking cessation’ (12.8%, 15/117) was the least preferred. Additional services mentioned include the availability of traditional medicines and reminding patients to take their medicines.

Understanding of pharmacists and satisfaction with pharmacists

This section focused on the respondents’ understanding of the pharmacists’ role, their experience with the pharmacists as well as their satisfaction. The details of the responses are shown in Tables 3 and 4. Majority of respondents (n = 179, 80.6%) were aware of the role of a pharmacist, as shown in Table 3, ‘Dispense medicines’ (n = 194, 87.4%), ‘Counselling patients regarding their medications’ (n = 169, 76.1%), and ‘Collaborate with doctors in monitoring patient medication use’ (n = 126, 56.8%) were the most perceived role of a pharmacist, while ‘Policymakers’ (n = 17, 7.7%) and ‘Businessmen’ (n = 24, 10.8%) were the least perceived role.

Table 3 Perception of the role of pharmacists, experience with community pharmacists, preference for treatment of minor illnesses, and expectations of pharmacists
Table 4 Satisfaction of pharmacies and pharmacists

Table 3 shows that 78.4% (n = 174) of respondents mentioned that the pharmacists explain the use of the medicines, the possible side effects, and any warnings when dispensing. More than half (n = 119, 53.6%) of the respondents had the experience of asking pharmacists for advice. It was also noted that most respondents (n = 156, 70.3%) were not offered counselling services by the pharmacists. Among those that have received counselling, they had positive views on the counselling sessions as several respondents were very satisfied (n = 7, 10.8%) or satisfied (n = 25, 38.5%) with the sessions. In addition, 82.0% (n = 182) of respondents reported that the pharmacists answered their queries well.

When asked about where they would go when they have minor illnesses, 52.7% (n = 117) of respondents chose to see a doctor in the hospital or private clinic and 41.0% (n = 91) to purchase OTC medicines from the pharmacy nearby. 3.6% (n = 8) of respondents would prefer to stay at home and rest until their condition improves (Table 3).

Respondents were then asked about their expectations of a pharmacist. All options were chosen at least once, with ‘Able to tell me about the medication (use, strength, dose, how to take it), and ‘Able to tell me about the possible side effects and potential warnings’ being the most selected options, at 90.5% (n = 201) and 88.7% (n = 197), respectively. Respondents least expect pharmacists to offer lifestyle advice related to their condition, with 39.2% (n = 87) of respondents choosing it. Other answers provided include being polite when talking to a patient over the counter as well as good customer service. Details of the respondents’ expectations are summarized in Table 3.

The following questions required respondents to rate their satisfaction with several aspects of the pharmacists and pharmacy on a scale of 1–5, with 1 being very satisfied/very good and 5 being very unsatisfied/very bad. Overall, all factors were positively viewed by most respondents, although the percentage of respondents who had positive views on the pharmacy’s waiting time was similar to that of the negative view; 28.4% (n = 63) vs 23.5% (n = 52), respectively (Table 4).

Views on the dispensing separation system

This section explores the respondents’ views on the concept of dispensing separation (DS), a system, where the role of prescribing and dispensing medications is separated, usually performed by different healthcare professionals.

A significant majority of respondents were not familiar with the term “dispensing separation” (76.1%, n = 169), and many were unaware of its implementation in other countries (84.7%, n = 188). When asked if Brunei should implement this system, most respondents expressed uncertainty (57.7%, n = 128), with a similar proportion also unsure whether Brunei is prepared for such a system (62.6%, n = 139).

However, a notable number of respondents did believe that Brunei should implement the DS system (36.5%, n = 81) and felt prepared for its execution (24.8%, n = 55). Those who supported the DS system’s implementation cited reasons, such as improved safety, convenience, and adequate manpower. Conversely, respondents who disagreed with its implementation mainly pointed to a perceived lack of manpower and a preference for the existing practice.

Among those unsure about whether Brunei is ready for DS system implementation, the most common reason given was unfamiliarity with the DS system and a lack of knowledge about it. The details of respondents’ views on DS are summarized in Table 5.

Table 5 Respondents’ views on dispensing separation

Private community pharmacies

A significant number of respondents reported that there is always a pharmacist available (n = 81, 36.5%) and that pharmacists or staff asked for relevant medical histories before selling medication (n = 77, 34.7%). However, many respondents are unaware of the services provided by private community pharmacies (n = 154, 69.4%), and a considerable proportion have never or rarely been to a community pharmacy. Details of the responses are shown in Table 6.

Table 6 Experience in private community pharmacies

Understanding of P medicines

More than half of the respondents (n = 128, 58.1%) do not know what a P medicine is. Among those who have ever purchased a P medicine, the majority (n = 53, 79.1%) bought it from private community pharmacies. Details are summarized in Table 7. The respondents were almost equally divided on whether Brunei should classify more medicines as P medicines, so that consumers can buy them at community pharmacies, with slightly more respondents (50.9%) being unsure, as compared to respondents that agree (41.9%).

Table 7 Knowledge of P medicines

Relationship between demographic variables, satisfaction with pharmacists, views on dispensing Separation, private community pharmacies, and P medicines

One-way ANOVA and independent t test were used for comparison. No significant differences were found between demographic variables and their satisfaction with the pharmacists (see Appendix 2).

However, significant differences were found among different age groups regarding the view score on dispensing separation system (p = 0.021), as shown in Table 8. The participants of age 41–50 years were having high score, as shown in Table 8.

Table 8 Views score on dispensing separation system vs private community pharmacies and satisfaction score having/with pharmacist

Binary logistic regression was used for the comparison of related to understanding of P medicines; however, no statistically significant difference was observed among the response in comparison with gender, age, education, and district of residence (see Appendix 2).

Discussion

This study evaluated the perceptions of the general public towards the services offered by community pharmacies, their interactions with and comprehension of community pharmacists, opinions on dispensing separation, private community pharmacies, and understanding of P medicines.

Pharmacy usage and preference for services

The respondents indicated a preference for receiving medical treatment from public institutions, government organizations, or private clinics, reflecting a potentially stronger trust in physicians [19, 20]. A study examining consumer perceptions of community pharmacists revealed a predilection for physicians in the context of health problem consultations [19].

Most respondents favoring public institutions or private clinics attributed this preference to familiarity or convenience. The shorter wait times at private clinics were highlighted as a distinct advantage. Furthermore, respondents who preferred public institutions often cited financial considerations, as services in Brunei’s public institutions are typically free or charged at a lower rate compared to private clinics and pharmacies, with just a nominal $1 registration fee.

The majority of respondents reported visiting community pharmacies every few months primarily to collect prescribed medications or buy over-the-counter drugs, mirroring findings from studies conducted in other countries [18, 19, 21]. This underlines a globally common perception of the principal roles of community pharmacies.

Specialized services, such as asthma and hypertension management, along with osteoporosis screening, were demonstrated to improve patients’ conditions and clinical outcomes (e.g., reduced blood pressure and increased peak expiratory flow) [22]. Screening programs also proved effective in enhancing disease detection and improving referral rates [23].

In our study, respondents displayed a readiness to utilize extended services if offered by community pharmacies. Screening services and treatment of minor illnesses received significant interest, whereas smoking cessation was least favored. A study conducted in Palestine found similar willingness among respondents to use extended services provided by community pharmacies [19]. It revealed a high consumer demand for such services, especially for screening procedures (blood cholesterol, blood glucose, blood pressure monitoring) and measurements of weight, height, and temperature [19]. A study from England indicated that participants were highly receptive to services, particularly health checks and advice related to cardiac conditions. Minor illnesses, being of low risk, are often deemed suitable for pharmacist-led treatment, while GP visits are reserved for chronic conditions [20].

A study from England also noted that smoking cessation services and alcohol advice were less popular [24]. One plausible explanation for the low popularity of smoking cessation in our study is the possibility of the respondents being non-smokers, therefore, having no interest in the service. Intriguingly, several respondents expressed interest in receiving medication reminders and appreciated the provision of traditional medicines.

Understanding of and satisfaction with pharmacists

The majority of respondents were cognizant of a pharmacist’s traditional role, primarily dispensing medicines (87.4%). In addition, counseling patients about their medications (76.1%) and collaborating with doctors to monitor patient medication (56.8%) were also identified as common roles of pharmacists. These findings align with a study by Mukattash et al., wherein dispensing medicines (46.2%) and counseling patients (34.6%) were recognized as the most crucial tasks of a pharmacist [14].

The study results indicated that respondents were well-versed with medication use, potency, and all relevant information concerning the medication before it was dispensed. Similarly, El-Kholy et al. reported that 72.8% of respondents concurred that pharmacists provided clear instructions on medication use [18].

Counseling services aim to enhance patients' understanding of their medicines and promote adherence [25]. Despite a significant proportion of respondents recognizing medication counseling as a typical role of a pharmacist, most respondents had not received these services. Potential barriers to providing counseling services could include time constraints or excessive workload of the pharmacists [6]. Among respondents who had received counseling, most expressed satisfaction with the session, appreciating the pharmacist’s knowledge and communication skills.

Respondents preferred to consult doctors in public institutions or private clinics for minor illnesses, consistent with their preferred destination for general medical treatment. However, the number of respondents choosing private pharmacies increased, suggesting that some trust private pharmacies to treat minor illnesses [19]. Gidman et al. reported that participants were more likely to visit community pharmacists for conditions deemed ‘low risk’ [20]. Some respondents might also be managing their minor conditions independently, viewing a doctor's visit as unnecessary [26].

Respondents demonstrated high expectations of pharmacists. Nearly all expected pharmacists to provide relevant information (use, strength, dosage, instructions for use, potential side effects, and warnings) about the medication before dispensing. This suggests a high degree of trust in the pharmacists' knowledge of medication. Another study reported that pharmacists were expected to counsel about potential interactions with other medications, use of the medications, and disease-related counseling [27]. Pharmacists are expected to provide drug information when dispensing medications, enabling patients to better understand their medication, be aware of potential side effects, and improve adherence [24]. Respondents also expected pharmacists to inquire about medical and medication history before dispensing and provide education on the use of their medical devices.

In general, respondents expressed satisfaction with the pharmacist's knowledge, attitude, professionalism, and communication skills, mirroring findings from a study that analyzed online patient feedback about pharmacies, where staff attitudes were perceived positively [28]. The impression of and relationship with the pharmacist were also viewed favorably.

While the general sentiment remained positive, a slightly higher proportion of respondents expressed dissatisfaction with the pharmacy’s waiting time. Similar findings have been reported in other studies [24, 28], with waiting times to receive medications from community pharmacies perceived as excessively long, ranging from hours to days [28]. An acceptable waiting time, not exceeding 15 min, was reported by respondents in an English study [24]. In addition, extended waiting times have been associated with decreased satisfaction [18].

Views on the dispensing separation system

The dispensing separation (DS) practice, where doctors solely prescribe and pharmacists dispense, is utilized in other countries and the public sector in Brunei. This system aims to enhance patient safety and reduce medication errors by enabling pharmacists to double-check prescriptions and prevent overprescribing [29].

The majority of respondents were unfamiliar with the term dispensing separation or its implementation overseas. Results from Malaysian studies revealed that 65% of respondents from Malaysia were unaware of DS [29], while 67.5% knew about the DS system implemented in other countries [15].

Private community pharmacies

Nearly half of the respondents had never visited private community pharmacies, possibly because there are fewer such establishments in Brunei, and they are not as heavily utilized as government community pharmacies located in health centres.

Among respondents who had visited private community pharmacies, most reported positive experiences, indicating the presence of a pharmacist, the gathering of relevant medical history, and the provision of medication information during the dispensing process. These results align with a study by El-Kholy et al., in which a majority of respondents confirmed the presence of a pharmacist to assist them (74.6%) and acknowledged that the pharmacist asked about their medication (45.5%) and medical conditions (49.1%) when preparing the prescription [18].

Despite visiting community pharmacies, respondents were largely unaware of the services provided there. This suggests that pharmacy owners or pharmacists may not be effectively promoting their services to their customers.

Respondents also expressed satisfaction with the pharmacist’s knowledge and communication skills, and felt that their queries were well-addressed. Pharmacists are often viewed as medication experts, and the public generally prefers consulting them for medication inquiries over doctors [14, 29]. Mukattash et al. found that the majority of respondents prefer to acquire information about medication from pharmacists [14]. However, a study in Qatar revealed that only 37% of respondents felt community pharmacists were knowledgeable enough and answered their questions satisfactorily, which is a lower percentage than found in this study (48.6%) [30].

In addition, respondents expressed satisfaction with the attention and time dedicated to them, suggesting that pharmacists devote substantial time to each customer to ensure adequate care [14].

In summary, the results indicate a satisfactory level of contentment with the availability and practices of pharmacists. However, gaps persist in public knowledge and usage of pharmacy services. These gaps could potentially be addressed through educational initiatives and awareness campaigns aimed at improving public comprehension of these issues.

The association between demographic variables and respondents’ views implies that specific strategies might need to be tailored to different age and gender groups for effective communication and implementation of changes in Brunei’s pharmacy sector.

Understanding of P medicines

Pharmacy (P) medicines can be purchased without a prescription in the presence of a pharmacist [16]. They are usually kept behind the counter and not displayed to the public.

The study’s results revealed that respondents are largely unfamiliar with the classification of medicines, as many did not know what a P medicine is and were unsure if they had ever bought one before. Among those who had bought P medicines before, a higher proportion had purchased them from private community pharmacies.

When asked whether Brunei should classify more medicines as P medicines to increase their availability at community pharmacies, respondents neither agreed nor disagreed strongly. This could be due to respondents’ lack of knowledge about P medicines and the potential benefits and risks associated with reclassification. Consequently, if Brunei intends to expand the P medicine category, it is important to assess both public understanding and pharmacists’ competency before making changes. The public should have adequate understanding of their conditions, while pharmacists should possess enough knowledge of the conditions and medications to provide appropriate recommendations.

The study’s results indicate a significant lack of awareness about key aspects of pharmaceutical services among respondents in Brunei. This includes unfamiliarity with the concept and implementation of a dispensing separation system, services provided by community pharmacies, and the classification of P medicines.

Limitations

The primary limitation of this study was the time constraints. Due to these constraints and the low number of respondents, the target sample size was not met. In addition, the majority of respondents were female, potentially skewing results towards the perspectives of the female population over the male population. Moreover, the study employed online questionnaires, which may have limited the participation of older generations. The respondents were also largely from an undergraduate educational background, but the study did not probe further into their specific fields of study. This limited the study's ability to correlate educational field with respondents’ understanding and in-depth knowledge, posing another potential limitation.

Recommendations for future research

To address the limitations of this study, several recommendations can be made for future research. First, efforts should be made to recruit an equal proportion of male and female respondents to avoid a skewed gender ratio. Second, in-person surveys could be conducted to reach a wider and more diverse demographic, including older populations. Furthermore, future research could explore the perceptions of healthcare professionals and stakeholders regarding the feasibility of dispensing separation (DS) in Brunei through qualitative studies.

Conclusion

In general, the public in Brunei primarily prefers to visit doctors for medical treatment and uses community pharmacies predominantly for prescription collection or purchasing over-the-counter medications. Nevertheless, they are open to using additional services provided by community pharmacists, particularly screening services and treatment for minor illnesses. However, public knowledge about the dispensing separation system and the classification of medications is limited. As such, educational and awareness initiatives will be crucial in enhancing public understanding of pharmaceutical services and the roles of pharmacists before implementing any changes in the sector.

Appendix 1

Section 1: demographics

  1. 1.

    Gender

  2. 2.

    Female

  3. 3.

    Male

  4. 4.

    Age (years)

  5. 5.

    Nationality

  6. 6.

    Bruneian

  7. 7.

    Permanent resident

  8. 8.

    Other:

  9. 9.

    Highest education level

  10. 10.

    Postgraduate

  11. 11.

    Undergraduate

  12. 12.

    Diploma

  13. 13.

    Sixth form graduate (A Levels)

  14. 14.

    Secondary graduate (O Levels)

  15. 15.

    Others

  16. 16.

    Please state the country that you have completed your undergraduate and graduate study

  17. 17.

    Which district do you live in

  18. 18.

    Brunei Muara

  19. 19.

    Tutong

  20. 20.

    Belait

  21. 21.

    Temburong

Section 2: pharmacy usage and preference of services

  1. 7.

    Please state your preferred place to receive usual medical treatment

  2. 8.

    Public/government institution

  3. 9.

    Private clinic

  4. 10.

    Private pharmacy (such as Guardian Pharmacy)

  5. 11.

    Why?

  6. 12.

    My doctor asked me to

  7. 13.

    I am used to it

  8. 14.

    People around me visited there

  9. 15.

    Less waiting time

  10. 16.

    It is more convenient for me

  11. 17.

    Other

  12. 18.

    How often do you visit the community pharmacy?

  13. 19.

    Once a week

  14. 20.

    Once a month

  15. 21.

    Once every few months

  16. 22.

    Other

  17. 23.

    When was the last time you visited the pharmacy?

  18. 24.

    A week ago

  19. 25.

    Few weeks ago

  20. 26.

    Last month

  21. 27.

    Few months ago

  22. 28.

    A year ago

  23. 29.

    More than a year ago

  24. 30.

    What is your purpose of visiting the community pharmacy?

  25. 31.

    Collect medicines from prescription

  26. 32.

    Purchase over-the-counter medications

  27. 33.

    Counselling for medication uses

  28. 34.

    Ask for advice on medications

  29. 35.

    Other

  30. 36.

    Would you be willing to use other services provided by the pharmacy, other than the ones stated above?

  31. 37.

    Yes

  32. 38.

    No

  33. 39.

    Maybe

  34. 40.

    If yes, what are the services you wish to receive from the community pharmacies?

  35. 41.

    Screening services (e.g., blood pressure, blood glucose)

  36. 42.

    Medicine use review

  37. 43.

    Smoking cessation

  38. 44.

    Lifestyle advices

  39. 45.

    Weight management program

  40. 46.

    Vaccination

  41. 47.

    Asthma care

  42. 48.

    Supplements and herbal medicine recommendation/counselling

  43. 49.

    Skin care management

  44. 50.

    Osteoporosis care (bone problems)

  45. 51.

    Treating minor illness (e.g., cough and cold, diarrhea, constipation)

  46. 52.

    Follow-up services

  47. 53.

    Other

Section 3: understanding of pharmacists and satisfaction with pharmacists

  1. 14.

    Are you aware of the role of a pharmacist?

  2. 15.

    Yes

  3. 16.

    No

  4. 17.

    What do you think pharmacists do? (Tick all that applies)

  5. 18.

    Dispense medicines

  6. 19.

    Counselling patients regarding their medications

  7. 20.

    Buying and selling medicines

  8. 21.

    Monitor patient medication therapy

  9. 22.

    Health promotion

  10. 23.

    Collaborate with doctors in monitoring patient medication use

  11. 24.

    Medication delivery service

  12. 25.

    Home medicine review

  13. 26.

    Policymakers

  14. 27.

    Businessmen

  15. 28.

    Other

  16. 29.

    Do the pharmacists explain the use of the medicines, the possible side effects, and any warnings when dispensing?

  17. 30.

    Yes

  18. 31.

    No

  19. 32.

    Have you ever asked the pharmacists for advice regarding your medicine and condition?

  20. 33.

    Yes

  21. 34.

    No

  22. 35.

    Do the pharmacists provide counselling services?

  23. 36.

    Yes

  24. 37.

    No

  25. 38.

    If your answer was yes to the previous question, please rate your satisfaction of the counselling services

  26. 39.

    1 (very satisfied) to 5 (very unsatisfied)

  27. 40.

    Do the pharmacists answer your queries well?

  28. 41.

    Yes

  29. 42.

    No

  30. 43.

    Where do you normally go when you have a minor illness (e.g., cough and cold, diarrhea, constipation)?

  31. 44.

    To see a doctor in the hospital or private clinic

  32. 45.

    To purchase OTC medicines from the pharmacy nearby (e.g., Guardian)

  33. 46.

    Other

  34. 47.

    What are your expectations of a pharmacist? (Tick all that applies)

  35. 48.

    Able to tell me about the medication (use, strength, dosage, how to take it)

  36. 49.

    Able to tell me about the possible side effects and potential warnings

  37. 50.

    Should be an expert in OTC medicines

  38. 51.

    Able to tell me how to use my medical devices

  39. 52.

    Should ask me all relevant questions (medical conditions, medications, allergies etc.) before dispensing the medication

  40. 53.

    Able to answer all my queries

  41. 54.

    Able to offer some lifestyle advices related to my condition

  42. 55.

    Able to respect my confidentiality

  43. 56.

    Able to contact my doctor if there is anything they need to clarify for my prescription

  44. 57.

    Able to detect any medication error and prevent them from happening

  45. 58.

    Other

  46. 59.

    Please rate your satisfaction of the pharmacy’s waiting time

  47. 60.

    1 (very satisfied) to 5 (very unsatisfied)

  48. 61.

    Please rate your overall impression of the pharmacists

  49. 62.

    1 (very good) to 5 (very bad)

  50. 63.

    Please rate your satisfaction of the pharmacists’ knowledge

  51. 64.

    1 (very satisfied) to 5 (very unsatisfied)

  52. 65.

    Please rate your satisfaction of the pharmacists’ attitude

  53. 66.

    1 (very satisfied) to 5 (very unsatisfied)

  54. 67.

    Please rate your satisfaction of the pharmacists’ professionalism

  55. 68.

    1 (very satisfied) to 5 (very unsatisfied)

  56. 69.

    Please rate your satisfaction of the pharmacists’ communication skills

  57. 70.

    1 (very satisfied) to 5 (very unsatisfied)

  58. 71.

    Please rate your relationship with the pharmacists

  59. 72.

    1 (very good) to 5 (very bad)

Section 4: views on the dispensing separation system

Dispensing separation is the separation between prescribing and dispensing, where physicians solely prescribe and pharmacists solely dispense. In Brunei, it is practiced in the hospitals and government health centres but not in private clinics and pharmacies. In the private sector, the doctor will both prescribe and dispense or the dispensing will normally be done by a non-pharmacist.

  1. 30.

    Have you heard of the term dispensing separation?

  2. 31.

    Yes

  3. 32.

    No

  4. 33.

    Maybe

  5. 34.

    Are you aware that other countries have implemented the dispensing separation system? (e.g., Japan, Korea, Taiwan)

  6. 35.

    Yes

  7. 36.

    No

  8. 37.

    Do you think Brunei should implement the dispensing separation system? (For private sector)

  9. 38.

    Yes

  10. 39.

    No

  11. 40.

    I do not know

  12. 41.

    Do you think Brunei is prepared to implement the dispensing separation system? (For private sector)

  13. 42.

    Yes

  14. 43.

    No

  15. 44.

    I do not know

  16. 45.

    Why do you think so?

Section 5: private community pharmacies

  1. 35.

    There is always a pharmacist available

  2. 36.

    Yes

  3. 37.

    No

  4. 38.

    I have never or rarely been to a private community pharmacy

  5. 39.

    The pharmacists or staff asked me about my medication history, medical condition history, allergies, symptoms before selling the medication

  6. 40.

    Yes

  7. 41.

    No

  8. 42.

    I have never or rarely been to a private community pharmacy

  9. 43.

    Are you aware of any services offered by the private community pharmacies?

  10. 44.

    Yes

  11. 45.

    No

  12. 46.

    The pharmacist or staff tells me about the use, dosage, possible side effects, warnings, and other relevant information of the medicine before selling/dispensing it to me

  13. 47.

    Yes

  14. 48.

    No

  15. 49.

    I have never or rarely been to a private community pharmacy

  16. 50.

    The pharmacist or staff answer my queries well

  17. 51.

    Yes

  18. 52.

    No

  19. 53.

    I have never or rarely been to a private community pharmacy

  20. 54.

    The pharmacist spends enough time with me

  21. 55.

    Yes

  22. 56.

    No

  23. 57.

    I have never or rarely been to a private community pharmacy

Section 6: understanding of P medicines

Pharmacy (P) medicines are medicines that can only be bought from a pharmacy and in the presence of a pharmacist. They are normally stored behind the counter in pharmacies and are not in the open areas.

  1. 41.

    Do you know what a P medicine is?

  2. 42.

    Yes

  3. 43.

    No

  4. 44.

    Have you ever purchased any P medicine?

  5. 45.

    Yes

  6. 46.

    No

  7. 47.

    Not sure

  8. 48.

    If yes, where do you buy it from?

  9. 49.

    Hospital

  10. 50.

    Private community pharmacies

  11. 51.

    Other

  12. 52.

    Do you think Brunei should classify more medicines as P medicines, so that consumers can buy them at community pharmacies

  13. 53.

    Yes

  14. 54.

    No

  15. 55.

    No comment

Appendix 2 Comparison related to the understanding of P medicines

 

Do you know what P medicine is?

Have you ever purchased any P medicine?

Do you think Brunei should classify more medicines as P medicines, so that consumers can buy them at community pharmacies?

OR (95%CI)

OR (95%CI)

OR (95%CI)

Gender

 Male

Reference

Reference

Reference

 Female

1.540 (0.855;2.775)

1.335 (0.707;2.251)

1.288 (0.720;2.307)

Age in years

 18–30 years

Reference

Reference

Reference

 31–40 years

0.996 (0.467; 2.124)

0.709 (0.323; 1.556)

0.947 (0.444; 2.020)

 41–50 years

0.629 (0.202; 1.955)

0.473 (0.151; 1.481)

0.310 (0.092; 1.049)

 51–60 years

1.223 (0.283; 5.293)

1.216 (0.237; 6.240)

1.163 (0.269; 5.034)

 More than 60 years

   

Education

 Postgraduate

Reference

Reference

Reference

 Undergraduate

1.051 (0.428; 2.5770

0.558 (0.238; 1.456)

0.556 (0.229; 1.350)

 Diploma

1.091 (0.298; 3.993)

0.951 (0.237; 3.810)

0.667 (0.187; 2.381)

District of residency

 Brunei Muara

Reference

Reference

Reference

 Tutong

1.379 (0.556; 3.420)

0.626 (0.478; 3.416)

1.067 (0.438; 2.596)

 Belait

1.155 (0.428; 3.120)

0.773 (0.398; 3.450)

0.549 (0.207; 1.457)

 Temburong

0.245 (0.025; 2.403)

0.796 (0.138; 13.295)

0.686 (0.094; 4.980)

Binary logistic regression was used, OR: Odd Ratio, CI: Confidence Interval; * p value less than 0.05 statistically significant.

Availability of data and materials

Please contact author for data requests.

Abbreviations

DS:

Dispensing separation

GDP:

Good dispensing practice

CPSA:

Community Pharmacy Services Agreement

POM:

Prescription only medicines

P-medicine:

Pharmacy medicine

GSL:

General sales list

BDMCA:

Brunei Darussalam Medicines Control Authority

UBD:

Universiti Brunei Darussalam

UTB:

Universiti Teknologi Brunei

UNISSA:

Universiti Islam Sultan Sharif Ali

IBTE:

Institute of Brunei Technical Education

LCB:

Laksamana College of Business

PB:

Politeknik Brunei

PAPRSB IHSREC:

Pengiran Anak Puteri Rashidah Institute of Health Sciences Research Ethics Committee

References

  1. Mossialos E, et al. From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119(5):628–39.

    Article  PubMed  Google Scholar 

  2. Smith AJ, et al. Service provision in the wake of a new funding model for community pharmacy. BMC Health Serv Res. 2018;18(1):307.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Berbatis CG, et al. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s National Pharmacy Database Project. Int J Pharm Pract. 2007;15(3):185–91.

    Article  Google Scholar 

  4. Son KB, Choi S, Kim D. Public perceptions of the roles and functions of community pharmacies in the era of expanding scopes of pharmaceutical practice: a questionnaire survey in South Korea. Health Soc Care Community. 2019;27(4):1095–101.

    Article  PubMed  Google Scholar 

  5. Lindsey L, et al. Helpful advice and hidden expertize: pharmacy users’ experiences of community pharmacy accessibility. J Public Health (Oxf). 2017;39(3):609–15.

    PubMed  Google Scholar 

  6. Hattingh HL, et al. Utilization of community pharmacy space to enhance privacy: a qualitative study. Health Expect. 2016;19(5):1098–110.

    Article  PubMed  Google Scholar 

  7. Ministry of Health, B.D. Community Pharmacy Services. Available from: https://www.moh.gov.bn/SitePages/Community%20Pharmacy.aspx.

  8. Armour CL, Smith L, Krass I. Community pharmacy, disease state management, and adherence to medication a review. 2008.

  9. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25(2):144–53.

    Article  PubMed  Google Scholar 

  10. Benrimoj SI, Frommer MS. Community pharmacy in Australia. 2004.

  11. Kember J, Hodson K, James DH. The public’s perception of the role of community pharmacists in Wales. Int J Pharm Pract. 2018;26(2):120–8.

    Article  PubMed  Google Scholar 

  12. <CPSA consolidated 2017.pdf>.

  13. Hasan S, et al. Patient expectations and willingness to use primary care pharmacy services in the United Arab Emirates. Int J Pharm Pract. 2015;23(5):340–8.

    Article  PubMed  Google Scholar 

  14. Mukattash TL, et al. Pharmaceutical care in community pharmacies in Jordan: a public survey. Pharm Pract (Granada). 2018;16(2):1126.

    Article  PubMed  Google Scholar 

  15. Loo JSE, et al. Separation of prescribing and dispensing in Malaysia: public perception of pharmacists’ roles and agreement towards a separation policy. J Pharm Pract Res. 2019;50(1):5–12.

    Article  Google Scholar 

  16. Agency, M.a.H.p.R. Medicines: reclassify your product. 2014. cited 2022; Available from: https://www.gov.uk/guidance/medicines-reclassify-your-product.

  17. Ministry of Health, B.D. Poisons Act (2003). Available from: https://www.moh.gov.bn/SitePages/Poisons%20Act.aspx.

  18. El-Kholy AA, et al. Publics’ perceptions of community pharmacists and satisfaction with pharmacy services in Al-Madinah City, Saudi Arabia: a cross sectional study. Medicina (Kaunas). 2022;58(3):432.

    Article  PubMed  Google Scholar 

  19. Khdour MR, Hallak HO. Societal perspectives on community pharmacy services in West Bank—Palestine. 2012.

  20. Gidman W, Ward P, McGregor L. Understanding public trust in services provided by community pharmacists relative to those provided by general practitioners: a qualitative study. BMJ Open, 2012; 2(3).

  21. Duxbury K. and K. Fisher: Public perceptions of community pharmacy; 2022.

    Google Scholar 

  22. George PP, et al. The evolving role of the community pharmacist in chronic disease management—a literature review. Ann Acad Med Singap. 2010;39:861.

    Article  PubMed  Google Scholar 

  23. Hermansyah A, Sainsbury E, Krass I. Community pharmacy and emerging public health initiatives in developing Southeast Asian countries: a systematic review. Health Soc Care Community. 2016;24(5):e11-22.

    Article  PubMed  Google Scholar 

  24. Saramunee K. General public views on community pharmacy services in public health. Liverpool John Moores University; 2013.

    Google Scholar 

  25. Alabid AH, Ibrahim MI, Hassali MA. Do professional practices among Malaysian private healthcare providers differ? A comparative study using simulated patients. J Clin Diagn Res. 2013;7(12):2912–6.

    PubMed  PubMed Central  Google Scholar 

  26. Wazaify M, et al. Societal perspectives on the role of community pharmacists and over-the-counter drugs in Jordan. Pharm World Sci. 2008;30(6):884–91.

    Article  PubMed  Google Scholar 

  27. Iffat W, et al. Perceived barriers and expectations of general public for establishing community pharmacy in Pakistan. World J Pharmacy Pharm Sci. 2015.

  28. Loo J, Greaves G, Lewis PJ. Exploring patients’ pharmacy stories: an analysis of online feedback. Int J Clin Pharm. 2021;43(6):1584–93.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Abdul Ghani N, Kamaruddin NF, Mokhtar NI. Awareness and perception towards implementation of dispensing separation in Malaysia: a cross-sectional study. Malays J Med Sci. 2021;28(1):87–96.

    PubMed  PubMed Central  Google Scholar 

  30. El Hajj MS, Salem S, Mansoor H. Public’s attitudes towards community pharmacy in Qatar: a pilot study. Patient Prefer Adherence. 2011;5:405–22.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

Study design: YWX; HPG; LCM. Data collection: YWX; data analysis: IUR; YWX; NS. Write-up initial draft: YWX; YMA-W; AH. Review of final draft: HPG; LCM; IUR. All authors approved the submission of the final manuscript.

Corresponding authors

Correspondence to Hui Poh Goh or Andi Hermansyah.

Ethics declarations

Ethics approval and consent to participate

Ethical approval was obtained from Pengiran Anak Puteri Rashidah Institute of Health Sciences Research Ethics Committee (PAPRSB IHSREC), Universiti Brunei Darussalam (UBD/PAPRSBIHSREC/2022/115) and written informed consent was obtained from the participants.

Consent for publication

All authors gave consent for this publication.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xuan, Y.W., Goh, H.P., Rehman, I.U. et al. Assessing consumers’ perception and demand on the community pharmacists’ dispensing. J of Pharm Policy and Pract 16, 162 (2023). https://doi.org/10.1186/s40545-023-00609-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40545-023-00609-1

Keywords